www.fdanews.com/articles/176861-vigilant-biosciences-introduces-oncalert-labs-oramark-test
Vigilant Biosciences Introduces OncAlert Labs OraMark Test
May 31, 2016
Vigilant Biosciences has unveiled its OncAlert Labs OraMark Test for the early detection of oral cancer, the company announced Tuesday.
The oral rinse test is intended to measure a “tumor-initiating and stem cell-associated biomarker” for early oral cancer detection, the company said.
The test will be available to clinicians in the U.S. as a laboratory developed test during the latter half of the year. — Anisa Jibrell